Inactief instrument

Andere talen Forbion European Acquisition Corp. Nasdaq

Aandelen

FRBN.U

KYG3619H1285

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

EnGene, Inc. completed the acquisition of Forbion European Acquisition Corp. from a group of shareholders in a reverse merger transaction.	01/11
Forbion European Acquisition Corp.(NasdaqGM:FRBN) dropped from NASDAQ Composite Index	31-10-23
Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting	30-10-23
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30-10-23
Wall Street Set to Open Higher Friday; Core Inflation Rises 0.3% Matching Forecast	27-10-23
Top Premarket Decliners	25-10-23
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding	13-09-23
Forbion European Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Forbion European Acquisition Corp. announced that it has received $1.265 million in funding from Forbion Growth Sponsor Feac I B.V.	06-06-23
EnGene, Inc. and Forbion European Acquisition Corp. ("FEAC", Nasdaq: FRBN) Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies - Form 8-K	17-05-23
Forbion European Acquisition Corp. entered into a business combination agreement to acquire enGene, Inc from shareholders.	17-05-23
Forbion European Acquisition Corp. announced that it has received $56.891682 million in funding from a group of investors	16-05-23
Forbion European Acquisition Corp. announced that it received $56.891682 million in funding from enGene Holdings, and other investors	16-05-23
Forbion European Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	12-05-23
Forbion European Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	30-03-23
Forbion European Acquisition Corp. Auditor Raises 'Going Concern' Doubt	30-03-23
Forbion European Acquisition Corp. announced that it expects to receive $0.9 million in funding	24-03-23
Forbion European Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10-11-22
Certain Class B Ordinary Shares of Forbion European Acquisition Corp. are subject to a Lock-Up Agreement Ending on 8-JUN-2022.	08-06-22
Forbion European Acquisition Corp.(NasdaqGM:FRBN) added to NASDAQ Composite Index	07-02-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Forbion European Acquisition Corp. Nasdaq

Aandelen

FRBN.U

KYG3619H1285

Andere talen

Filters